212
Participants
Start Date
June 1, 2025
Primary Completion Date
June 1, 2029
Study Completion Date
June 1, 2029
Hydrocortisone Hemisuccinate: 200 mg per day.
The hydrocortisone hemisuccinate is a powder and solvent for injectable solution at 100 mg. The powder must be dissolved in the solvent to ensure final isotonicity. The solution must be used within 24 hours. The injection is performed as a slow direct IV injection, either via an electric syringe pump or as a bolus of 50 mg every 6 hours
reduction of the level of immunosuppression
"In this arm, the usual immunosuppressive treatment of the patients will be discontinued.~Patients will receive hydrocortisone hemisuccinate 200 mg per day (slow direct intraveinous injection of 50 mg four times a day, or through an electric syringe pump)."
University Hospital, Strasbourg, France
OTHER